TAO Synergies Inc.
- TAOX
- NASDAQ
- Application software
- Bryostatin-1 Therapeutics
- Alzheimer's/Neurodegenerative Drugs
$3.25
Today −2.69%Quote Oct 19, 2026, 08:00 PM UTC
−18.14%over the last month
Max drawdown −30.4%From 1-month high −30.4%3 months −6.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About TAO Synergies
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders.
Sector
Technology
Industry
Application software
Exchange
NASDAQ
Employees
5
Market value
$25.5M
Quote Oct 19
Floor
$3.20
1.5% below price
Resistance
$3.30
1.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TAOXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free